David Mulham Mulham - 03 Feb 2023 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CHIEF SALES OFFICER
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
03 Feb 2023
Transactions value $
$0
Form type
4
Filing time
07 Feb 2023, 12:02:13 UTC
Previous filing
10 Feb 2022
Next filing
08 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction USNA Common Stock Options Exercise +1.08K +11.63% 10.4K 03 Feb 2023 Direct F1, F2
transaction USNA Common Stock Options Exercise +1.14K +10.98% 11.5K 04 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Options Exercise $0 -1.08K -7.42% $0.00 13.5K 03 Feb 2023 Common Stock 1.08K Direct F1, F3
transaction USNA Restricted Stock Units Options Exercise $0 -1.14K -8.45% $0.00 12.3K 04 Feb 2023 Common Stock 1.14K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 Includes an adjustment of 90 shares owned by the reporting person, which were over reported on the previous Form 4.
F3 Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020.
F4 Restricted Stock Units vest 25% on the anniversary of February 4th, 2019.